On 2026-10-01, Guggenheim raised its NTRA price target to $475 from $360 (+31.9%).
Guggenheim 于 2026-10-01 将 NTRA 目标价上调至 $475，此前为 $360，变动幅度 +31.9%。
For information only. Not investment advice.内容仅供参考，不构成投资建议。
NTRA regulatory decision: FDA Grants Breakthrough Device Designation for Natera's Multi-Cancer Early Detection AssayNatera, Inc.（NTRA）披露重大监管决定
Material Company Event · October 9, 2026公司公告 · 2026/10/9
Barclays raises NTRA target to $475 from $340Barclays 上调目标价 NTRA：$340 → $475
Rating Change · October 7, 2026评级变动 · 2026/10/7
Natera, Inc. (NTRA) falls 6.02% to $400.00Natera, Inc.（NTRA）下跌 6.02%，报 $400.00
Stock Price Move · October 6, 2026个股行情异动 · 2026/10/6
